Clinical Trials Logo

Oesophageal Varices clinical trials

View clinical trials related to Oesophageal Varices.

Filter by:
  • None
  • Page 1

NCT ID: NCT03776955 Recruiting - Oesophageal Varices Clinical Trials

Beta-blockers for Oesophageal Varices

BOPPP
Start date: June 17, 2019
Phase: Phase 4
Study type: Interventional

To determine if carvedilol reduces the rate of variceal haemorrhage in patients with cirrhosis and small oesophageal varices

NCT ID: NCT02852161 Completed - Oesophageal Varices Clinical Trials

The Accuracy and Acceptability of Magnet Assisted Capsule Endoscopy in the Diagnosis of Esophageal Pathology: a Pilot Study

MACE
Start date: July 2016
Phase: N/A
Study type: Interventional

A pilot study to assess the accuracy and acceptability of a magnet assisted capsule endoscopy in detecting esophageal pathology compared to standard endoscopy.

NCT ID: NCT01335516 Completed - Clinical trials for Gastrointestinal Bleeding

Follow-up of Glypressin (Terlipressin) Clinical Efficacy in the Treatment of Bleeding Oesophageal Varices

Start date: November 2010
Phase: N/A
Study type: Observational

Terlipressin is an effective and safe treatment for bleeding caused by rupture of oesophageal varices, which are life-threatening complications of liver cirrhosis. Oesophageal varices are abnormal dilatation of veins occurring in the lower oesophagus, which can develop in patients with cirrhosis. Bleeding caused by rupture of these varices is a life-threatening complication with mortality between 20-50%. Such bleeding can be treated with drug therapy and/or endoscopic; endoscopic therapy consists of a flexible tube equipped with a camera at the terminal end, allowing for visualizing and treating the oesophageal varices. In this study, investigators will evaluate the safety and efficacy of terlipressin - Glypressin 1 mg, powder and solvent for solution for injection. The non-interventional observational study "Follow-up of Glypressin (terlipressin) clinical efficacy in the treatment of bleeding oesophageal varices" aims to demonstrate that administration of Glypressin (terlipressin 1 mg) controls the bleeding in such patients.